Literature DB >> 1970495

Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins.

J C McGrath1, S Monaghan, A G Templeton, V G Wilson.   

Abstract

1. The effects of an endothelium-dependent (acetylcholine) and an endothelium-independent (sodium nitroprusside) relaxant against noradrenaline-induced contractions were compared in three isolated superficial blood vessels of the rabbit, the lateral saphenous vein, plantaris vein and distal saphenous artery. Both produced concentration-related relaxations of all three vessels and were more effective against submaximal than maximal contractions to noradrenaline. Transient contractions to high concentration of acetylcholine occurred only in endothelium-intact preparations of saphenous vein and were inhibited by flurbiprofen. 2. In endothelium-denuded preparations sodium nitroprusside was 3 times more effective than in endothelium-intact preparations, while acetylcholine (less than 3 microM) was inactive. Sensitivity was similar for each relaxant: lateral saphenous vein greater than or equal to plantaris vein greater than distal saphenous artery. The similar profile of sodium nitroprusside and acetylcholine suggests that differences in susceptibility to endothelium-derived relaxing factor (EDRF) are caused by inter-vessel variations in the excitation-coupling process for noradrenaline. 3. Haemoglobin inhibited acetylcholine-induced relaxations in the endothelium-intact preparation of the lateral saphenous vein and distal saphenous artery, which suggests a similar EDRF in each preparation and the likelihood that this is a single substance, presumably nitric oxide. 4. The influence of basal, spontaneously released EDRF on alpha-adrenoceptor function was tested either by mechanical disruption of the endothelium or by adding haemoglobin to endothelium-intact segments. Endothelial disruption slightly reduced contractions to noradrenaline (NA) in distal saphenous artery but increased response size of lateral saphenous and plantaris veins, in the latter also increasing sensitivity to NA: haemoglobin mimicked endothelial disruption. Thus, basal release of EDRF like acetylcholine and nitroprusside was more effective in the veins than in the corresponding artery. 5. In lateral saphenous vein responses to phenylephrine were enhanced by endothelial disruption, but without change in sensitivity: responses to UK-14304, B-HT 920 and cirazoline, which had a relatively slow speed of onset of contraction were not affected. There was no correlation between enhancement and alpha-adrenoceptor sub-type although the agonists which were enhanced all activate alpha 1-adrenoceptors. Competitive antagonists failed to reveal an alpha-adrenoceptor subtype enhanced by endothelial disruption. However, effects of phenoxybenzamine suggest that alpha 1-adrenoceptors are necessary for the influence of basal EDRF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970495      PMCID: PMC1917498          DOI: 10.1111/j.1476-5381.1990.tb14657.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Nature of endothelium-derived relaxing factor: are there two relaxing mediators?

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Circ Res       Date:  1987-11       Impact factor: 17.367

2.  Selective inhibition by gossypol of endothelium-dependent relaxations augments relaxations to glyceryl trinitrate in rabbit coeliac artery.

Authors:  U Alheid; C Dudel; U Förstermann
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

4.  Variation in sensitivity of alpha adrenoceptor-mediated contraction of the vascular smooth muscle of rabbit elastic and muscular arteries is related to receptor affinity.

Authors:  M A Oriowo; J A Bevan; R D Bevan
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

5.  Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed.

Authors:  M D Randall; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

6.  Blockade by nifedipine of responses to intravenous bolus injection or infusion of alpha 1- and alpha 2-adrenoceptor agonists in the pithed rat.

Authors:  J C McGrath; J W O'Brien
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

8.  EDRF coordinates the behaviour of vascular resistance vessels.

Authors:  T M Griffith; D H Edwards; R L Davies; T J Harrison; K T Evans
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

9.  Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood
Journal:  Circ Res       Date:  1987-12       Impact factor: 17.367

10.  Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Blood Vessels       Date:  1988
View more
  8 in total

1.  alpha(2)-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: evidence for involvement of the vascular endothelium.

Authors:  R E Roberts; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  The effect of ischaemia on endothelium-dependent vasodilatation and adrenoceptor-mediated vasoconstriction in rat isolated hearts.

Authors:  P Pannangpetch; O L Woodman
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  Muscarinic receptors and drugs in cardiovascular medicine.

Authors:  P A van Zwieten; H N Doods
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

4.  Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study.

Authors:  M D Randall; D H Edwards; T M Griffith
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  The role of nitric oxide in the responses of the ovine digital artery to vasoactive agents and modification of these responses by endotoxin and cytokines.

Authors:  P Pawson; J Reid; A M Nolan
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Nitric oxide control of large veins in the toad Bufo marinus.

Authors:  Brad R S Broughton; John A Donald
Journal:  J Comp Physiol B       Date:  2005-02-03       Impact factor: 2.200

7.  Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs.

Authors:  O L Woodman; P Pannangpetch
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

8.  Bioengineered intestinal muscularis complexes with long-term spontaneous and periodic contractions.

Authors:  Qianqian Wang; Ke Wang; R Sergio Solorzano-Vargas; Po-Yu Lin; Christopher M Walthers; Anne-Laure Thomas; Martín G Martín; James C Y Dunn
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.